Today’s Veterinary Business Staff
Dechra Veterinary Products has received U.S. Food and Drug Administration approval of a generic version of Zoetis’ Zeniquin antibiotic for cats and dogs.
The new Marboquin tablets are indicated for the treatment of skin and soft tissue infections associated with bacteria susceptible to marbofloxacin, the active ingredient.
The once-a-day prescription medication was approved in dosages of 25, 50, 100 and 200 milligrams.
“Marboquin tablets should be given for two to three days beyond the cessation of clinical signs for a maximum of 30 days,” according to an FDA freedom of information summary.
“For the treatment of urinary tract infections, Marboquin tablets should be administered for at least 10 days. If no improvement is noted within five days, the diagnosis should be reevaluated and a different course of therapy considered.”
Did you know a subscription to Today’s Veterinary Business is free to qualified veterinary professionals? All you have to do is sign up here (and renew each year). You also can sign up to receive the Today’s Veterinary Business weekly e-newsletter.